Critical Success Factors for Industry Academic Collaborations - - PowerPoint PPT Presentation
Critical Success Factors for Industry Academic Collaborations Industry Academic Collaborations Mary Shire Vice President Research September 9 th 2015 September 9 th 2015 Content Content Context Context Changing Mission of Universities
Mary Shire Vice President Research September 9th 2015 September 9th 2015
Context
I d A d i C ll b i
www.ul.ie
National & International Policies
industry academic collaborations?
www.ul.ie
I d i l B d K l d B d E
leaders in this economy leaders in this economy
www.ul.ie
Traditional Role Teaching & Research for Public Good
U i i i i f i h
agenda of policy‐makers g p y
www.ul.ie
University industry research collaborations mechanisms for generating technology spill‐overs
forged between universities and its industrial environment environment
www.ul.ie
Mode 1
Publications Contract Research Government University Industry Contract Research IP Licensing Funding University Industry Discovery Verification & Exploitation
Mode 2
Collaborative Research Venture Creation Long-term relationship Government Funding Industry University Industry Venture Creation based partnering Industry Funding y Discovery & Verification Exploitation
www.ul.ie
Global Market $1 08T 2012 $1 6 T 2020
Global Market $1.08T, 2012 $1.6 T, 2020 (annual growth 7.8%) Exports Largest single exporting sector Exports Largest single exporting sector 52% of all Global Medicines Corporation Tax €1 Billion (25% of total corporation tax) p ( p ) Employment 24,000 Direct + 25,000 Indirect Education >65% are 3rd level graduates Education >65% are 3 level graduates Companies Over 120 companies – 13 of top 15 Compliance Unrivalled Record Compliance Unrivalled Record Investments
€3B new investment projects, 2000 new jobs
www.ul.ie
Gap in fundamental knowledge
size of the sector
No forum for industry industry knowledge sharing
precompetitive space
www.ul.ie
11
SSPC1 10 Industry 5 RPOS €8M SSPC2 22 Ind str 22 Industry 9 Irish RPOS €42M
Molecule to Material to Medicine
www.sspc.ie
F ilit t i t i d t ll b ti
in the precompetitive space C i f P i
“The SSPC was identified as The SSPC was identified as a benchmark model for collaboration – it was seen as an example of what has worked well in Ireland,
“What we do here in
Ireland amazes our international colleagues.
Academic Partners d
, having a critical mass of world‐class people, and delivering value for money” Michael Napier Janssen They are shocked when they hear we are collaborating with other big Pharma.”
www.sspc.ie
Industry Partners
Michael Napier, Janssen
Asia “I am not aware of activity of a similar scale anywhere else in the world. From my the world. From my understanding it is unique” International reviewer Europe North America Europe
www.ul.ie
www.ATTLAS.ie
techniques & techniques & capabilities
www.BPX.ie Top 10 user countries
www.Therapeutics.ie
(Bio)Pharma research capabilities
p
– Students & Post Doctoral Researchers – Upskilling & Bespoke
– Job Creation – FDI & SME – Job Creation FDI & SME – Job Retention Productivity Gains – Productivity Gains – Expanding remit of Irish sites
www.sspc.ie
7 Management support team 6 Y f F di 6 Years of Funding 9 Research Performing Organisations l ll b 12 International Collaboration Centres 20 Funded Projects 22 Companies supporting the research 36 Post‐Doctoral Researchers 38 Principal Investigators 42 Million Euro 60 PhD Studentships
www.sspc.ie
p
– Focus more on individuals and how to incentivise and reward them for collaboration reward them for collaboration – Some flexibility exhibited by both organisations in relation to intellectual property management to intellectual property management
www.sspc.ie
Synthesis/Crystal Growth and Design SSPC Pharmaceutical Formulation UGent Factories of the Future Invite Downstream Processing PROMIS Continuous Manufacturing CMAC
9 Centres 6 Co ntries 6 Countries
Biophama Formulation CPI Process Analytical CPI y Technology PMTC Process Simulation RCPE Upstream Processing NIBRT
www.sspc.ie
RCPE
22